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The signaling molecule nitric oxide (NO) exerts both ben-
eficial and deleterious effects on the vasculature; however,
the molecular signaling pathways are incompletely under-
stood. In smooth muscle cells (SMCs), the second mes-
senger cyclic guanosine monophosphate (cGMP)
mediates many effects of NO via the activation of cGMP-
dependent protein kinase type I (cGKI). The cGKI gene,
prkg1, encodes two isoforms, cGKIα and cGKIβ, both of
which are expressed in SMCs. The isoforms differ only in
their individual amino-terminal ends, which mediate the
interaction with partner proteins and target the kinases to
different subcellular compartments. Conventional knock-
outs carrying a cGKI null mutation (cGKI-/-) show multi-
ple phenotypes. These animals are difficult to analyse,
since most die before adulthood. Recently, two mouse
lines were generated that express either the cGKIα or
cGKIβ isoform exclusively in SMCs of cGKI-/- mice. These
mouse lines allow an isoform specific of individual
smooth muscle functions in adult "healthy" animals. 8-
Br-cGMP treatment of aortic SMCs from rescued mice
reduced norepinephrine- and depolarization-induced
Ca2+-increases to wild type levels. In addition, the 8-Br-
cGMP-induced relaxation of hormone contracted aorta
and jejunum was intact in the rescued animals. Finally,
telemetric blood pressure recordings in awake, freely mov-
ing mice revealed no differences between rescued and
control (wild type) mice. Taken together, these results sug-
gest that both isoforms can rescue a major part of the
cGMP/cGKI signaling in SMCs and either isoform can
compensate for the other in the modulation of vascular
tone. Irrespective of the reconstituting isozyme, 50% of
the rescued cGKIα and cGKIβ mice die within 52 weeks.
Abnormalities found in the mouse lines that possibly
cause premature death will be discussed.
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